Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Largest borrow rate increases among liquid names » 08:45
03/24/20
03/24
08:45
03/24/20
08:45
GME

GameStop

$3.81 /

+0.05 (+1.33%)

, SIL

APEX Silver Mines

$21.91 /

+0.75 (+3.54%)

, PSEC

Prospect Capital

$4.04 /

-0.77 (-16.01%)

, TAK

Takeda Pharmaceutical

$13.34 /

+0.07 (+0.53%)

, CVNA

Carvana

$35.81 /

+6.815 (+23.50%)

, VAL

Valaris

$0.50 /

-0.0238 (-4.54%)

, CHK

Chesapeake

$0.18 /

-0.0119 (-6.29%)

, OPK

Opko Health

$1.40 /

+ (+0.00%)

, TVTY

Tivity Health

$4.32 /

+0.4 (+10.20%)

, SKT

Tanger Factory

$5.94 /

-1.02 (-14.66%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: GameStop (GME) 101.37% +19.88, Global X Silver Miners (SIL) 3.17% +0.92, Prospect Capital (PSEC) 10.38% +0.65, Takeda Pharmaceutical (TAK) 0.85% +0.60, Carvana (CVNA) 3.08% +0.52, Valaris Plc (VAL) 3.90% +0.44, Chesapeake (CHK) 28.86% +0.43, Opko Health (OPK) 1.41% +0.42, Tivity Health (TVTY) 1.66% +0.39, and Tanger Factory (SKT) 10.33% +0.38.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Tivity Health price target lowered to $4 from $18 at Craig-Hallum » 08:58
03/16/20
03/16
08:58
03/16/20
08:58
TVTY

Tivity Health

$4.35 /

-0.57 (-11.59%)

Craig-Hallum analyst Alex…

Craig-Hallum analyst Alex Fuhrman lowered the firm's price target on Tivity Health to $4 from $18 to reflect the cost of social distancing. The analyst keeps a Hold rating on the shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Hot Stocks
Tivity Health announces agreement with HG Vora Capital to add new directors » 09:27
02/25/20
02/25
09:27
02/25/20
09:27
TVTY

Tivity Health

$12.99 /

+0.99 (+8.25%)

Tivity Health announced…

Tivity Health announced that its Board of Directors will appoint two new independent directors under an agreement with HG Vora Capital Management, a Tivity Health shareholder that owns approximately 9.9% of the company's outstanding shares. It is expected that HG Vora will name the new directors and they will join the Board in the next several weeks. They will be nominated for election at the company's 2020 Annual Meeting of Shareholders, replacing two current Board members who will not stand for reelection.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: Wall Street's top stories for Thursday » 17:12
02/20/20
02/20
17:12
02/20/20
17:12
MS

Morgan Stanley

$53.73 /

-2.58 (-4.58%)

, ETFC

E-Trade

$54.59 /

+9.65 (+21.47%)

, GS

Goldman Sachs

$232.79 /

-4.55 (-1.92%)

, LB

L Brands

$23.43 /

-0.565 (-2.35%)

, DLGNF

Dialog Semiconductor

$0.00 /

+ (+0.00%)

, IOTS

Adesto Technologies

$12.35 /

+4.36 (+54.57%)

, AMRC

Ameresco

$23.58 /

+0.775 (+3.40%)

, ENGIY

Engie SA

$0.00 /

+ (+0.00%)

, VIAC

ViacomCBS

$29.29 /

-6.405 (-17.95%)

, VIACA

ViacomCBS

$33.72 /

-5.855 (-14.80%)

, SIX

Six Flags

$32.10 /

-5.91 (-15.55%)

, PG

Procter & Gamble

$126.60 /

+1.14 (+0.91%)

, DPZ

Domino's Pizza

$373.75 /

+76.29 (+25.65%)

, STMP

Stamps.com

$157.83 /

+62.44 (+65.46%)

, CYH

Community Health

$6.64 /

+1.84 (+38.33%)

, TVTY

Tivity Health

$12.59 /

-10.32 (-45.05%)

, AAN

Aaron's

$45.49 /

-10.64 (-18.96%)

Stocks slid as Microsoft…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:28
02/20/20
02/20
12:28
02/20/20
12:28
MS

Morgan Stanley

$54.19 /

-2.12 (-3.76%)

, ETFC

E-Trade

$55.82 /

+10.88 (+24.21%)

, LB

L Brands

$24.44 /

+0.445 (+1.85%)

, IOTS

Adesto Technologies

$12.36 /

+4.37 (+54.69%)

, DLGNF

Dialog Semiconductor

$0.00 /

+ (+0.00%)

, VIAC

ViacomCBS

$29.80 /

-5.89 (-16.50%)

, SIX

Six Flags

$31.11 /

-6.9 (-18.15%)

, DPZ

Domino's Pizza

$367.08 /

+69.62 (+23.40%)

, STMP

Stamps.com

$151.07 /

+55.68 (+58.37%)

, CYH

Community Health

$6.72 /

+1.92 (+40.00%)

, TEVA

Teva

$13.15 /

-0.31 (-2.30%)

, TVTY

Tivity Health

$12.71 /

-10.2 (-44.52%)

, AAN

Aaron's

$45.10 /

-11.035 (-19.66%)

Stocks are down at midday…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
'Extremely disappointed' Barrington cuts Tivity Health target to $24 » 09:29
02/20/20
02/20
09:29
02/20/20
09:29
TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

Barrington analyst…

Barrington analyst Michael Petusky is "extremely disappointed" after Tivity Health reporter weaker than expected results and terminated its CEO. The Nutrition business is "still a mess," Petusky tells investors in a post-earnings research. Tivity shares "will almost without a doubt spend at least a couple of quarters in the penalty box," says the analyst. He lowered lowered his price target on Tivity to $24 from $38 but keeps an Outperform rating on the name.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Tivity Health downgraded to Hold from Buy at Craig-Hallum » 09:19
02/20/20
02/20
09:19
02/20/20
09:19
TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

Craig-Hallum analyst Alex…

Craig-Hallum analyst Alex Fuhrman downgraded Tivity Health to Hold from Buy with a price target of $18, down from $30. The analyst cited lower than expected 2020 guidance. While he continues to believe that there is significant potential for synergies by leveraging Tivity Health's nutrition segment to sell into healthcare channels, this opportunity has been eclipsed for now by what will likely be a third consecutive year of revenue declines for Nutrition segment. Given significant turnover in the senior leadership and the fact that January and February represent the biggest recruitment months for Nutrisystem, Fuhrman believes it is unlikely that this segment will show meaningful improvement in 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Jefferies sees too much uncertainty at Tivity Health, downgrades to Hold » 07:57
02/20/20
02/20
07:57
02/20/20
07:57
TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

As previously reported,…

As previously reported, Jefferies analyst David Styblo downgraded Tivity Health to Hold from Buy with a price target of $16, down from $28, as revenue in the Nutrition business is now expected to decline 9% in 2020, versus his prior expectation for it to increase 7-8%, and Healthcare segment margins are expected to be down nearly 200 basis points this year versus a modest increase in his previous model. Additionally, the CEO and head of Nutrition have exited the company, leaving "too many uncertainties," said Styblo, who is among at least four Wall Street analysts who lowered their ratings on Tivity this morning.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Tivity Health downgraded to Hold from Buy at SunTrust » 07:20
02/20/20
02/20
07:20
02/20/20
07:20
TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

SunTrust analyst David…

SunTrust analyst David MacDonald downgraded Tivity Health to Hold from Buy with a price target of $15, down from $25, after its Q4 earnings miss. The analyst cites the company's continued deterioration in the Nutrition business, margin pressure in Healthcare, management transitions and disappointing guidance, adding that while its fitness/nutrition business offers "conceptual attractiveness", its execution has been "elusive".

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Cantor downgrades Tivity Health to Neutral, cuts target to $17 from $40 » 06:56
02/20/20
02/20
06:56
02/20/20
06:56
TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Steven Halper downgraded Tivity Health to Neutral from Overweight with a price target of $17, down from $40. The company reported "disappointing" Q4 results and more importantly, its 2020 Nutrition segment guidance was well-below estimates, Halper tells investors in a research note. Given that Nutrition is a seasonal business, the analyst sees very few catalysts over the next nine months to drive the stock's valuation levels higher.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.